OM: Outset Medical Inc Market Price to Net Income Ratio

Symbol and logo of brand Outset (OM)

This chart shows the market price of Outset Medical, Inc. (OM) with the -1.10 indicator, which is based on the implementation of advanced blood purification methods via Tablo systems and their associated consumables. High growth potential is driven by the home dialysis model, where equipment installation guarantees recurring revenue from the sale of low-cost disposable components. However, FDA claims and potential supply chain disruptions are putting pressure on the company's market capitalization.

Outset Medical (OM) P/E Multiple: for the period 07/04/2022 - 11/11/2026
Flagship merchandise of Outset Medical, Inc.

The P/E ratio reflects the market value of a business relative to its actual earnings. This multiple compares market capitalization with historical returns, where trend inertia smooths out short-term fluctuations but may mask declining margins. By analyzing the P/E history, an investor assesses the pace at which the market recognizes management's strategy. For Outset Medical, Inc. (OM), the growth of this metric is justified by the implementation of Tablo systems through alliances that reduce clinic costs.

Key competitors

P/E Multiple dexcom.com|Price to Earnings Ratio PEN (Penumbra)|Market Price to Net Income Ratio NOVT|P/E Multiple HAE (Haemonetics Corp.)|Business Payback Period Inspire Medical Systems Inc (INSP)|PROCEPT BioRobotics - P/E Multiple|conmed.com (CNMD) - Price to Earnings Ratio|PLSE (Pulse Biosciences) - Price to Earnings Ratio|InMode Ltd - Company Value to Net Income|Price to Earnings Ratio Picard Medical Inc.|Price to Earnings Ratio Surmodics Inc. (SRDX)|P/E Multiple SENS|NPCE - Market Cap to Earnings|P/E Multiple TCMD (Tactile Medical)|SNWV: Price to Earnings Multiple|Electromed Inc - P/E Multiple|Business Payback Period LENSAR Inc LNSR|RCEL: P/E Multiple|Price to Earnings Ratio Profound Medical|BDMD (Baird Medical Investment Holdings) - P/E Multiple|P/E Multiple EDAP Medical|Price to Earnings Ratio Apyx Medical (APYX)|Price to Earnings Ratio ICCM (icecure-medical.com)|Pulmonx - Price to Earnings Ratio|Company Value to Net Income TELA|CytoSorbents Corp. - P/E Multiple|Market Cap to Earnings Sensus Healthcare Inc|Zynex Inc (ZYXI) - Price to Earnings Ratio|Market Cap to Net Income Ratio electroCore ECOR|Price to Earnings Ratio RBOT|P/E Multiple Inspira Technologies Oxy B.H.N. Ltd|P/E Multiple ICU|Business Payback Period iridex.com|Price to Earnings Ratio Intelligent Bio Solutions Inc. INBS|XAIR (Beyond Air Inc) - Market Cap to Net Income|PFSA - Price to Earnings Ratio|STRATA Skin Sciences (SSKN) - Price to Earnings Ratio|GCTK: P/E Multiple|Market Cap to Earnings nanovibronix.com (NAOV)|Price to Earnings Ratio Venus Concept Corp|Price to Earnings Multiple NUWE (Nuwellis Corp)|Price to Earnings Ratio AEMD (Aethlon Medical)|Market Price to Net Income Ratio ASXC|Price to Earnings Ratio Avinger AVGR|Biosig Technologies (BSGM) - Market Cap to Earnings|CUTR: Price to Earnings Ratio|KNW - P/E Multiple|NARI (Inari Medical, Inc.) - Price to Earnings Ratio|NVRO: Market Price to Net Income Ratio|Price to Earnings Ratio ReShape Lifesciences, Inc.|Silk Road Medical, Inc. (SILK) - Business Payback Period